Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Common Equity: 2020-2024

Historic Common Equity for Core Scientific (CORZ) over the last 5 years, with Dec 2024 value amounting to -$820.2 million.

  • Core Scientific's Common Equity fell 54.64% to -$1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 billion, marking a year-over-year decrease of 54.64%. This contributed to the annual value of -$820.2 million for FY2024, which is 37.40% down from last year.
  • Core Scientific's Common Equity amounted to -$820.2 million in FY2024, which was down 37.40% from -$596.9 million recorded in FY2023.
  • Over the past 5 years, Core Scientific's Common Equity peaked at $1.3 billion during FY2021, and registered a low of -$820.2 million during FY2024.
  • For the 3-year period, Core Scientific's Common Equity averaged around -$608.8 million, with its median value being -$596.9 million (2023).
  • Its Common Equity has fluctuated over the past 5 years, first soared by 9,186,269.86% in 2021, then tumbled by 130.52% in 2022.
  • Core Scientific's Common Equity (Yearly) stood at $14,600 in 2020, then skyrocketed by 9,186,269.86% to $1.3 billion in 2021, then plummeted by 130.52% to -$409.3 million in 2022, then plummeted by 45.83% to -$596.9 million in 2023, then slumped by 37.40% to -$820.2 million in 2024.